Cassava Sciences, Inc.
SAVA
$6.13
Change (1 day)
$42.20
Year High
$8.79
Year Low
Categories
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
Dividend history for Cassava Sciences, Inc. (SAVA)
Cassava Sciences, Inc. made a total of 2 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $2.75
Dividend payments for Cassava Sciences, Inc. (SAVA) from 2010 to 2012
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| December 13, 12 | $0.75 | $5.25 |
| December 13, 10 | $2.00 | $14.00 |